Cargando…
Long-Term Management of Generalised Anxiety Disorder with Low-Dose Continuous Infusions of Flumazenil: A Case Series
Background: Generalised anxiety disorder (GAD) is a common anxiety disorder associated with social and occupational impairment. Recently, a theory was postulated that dysfunctional gamma aminobutyric acid type A receptors (GABA(A)) are implicated in anxiety symptomology, which could be corrected by...
Autores principales: | Gallo, Alexander T., Addis, Stephen, Martyn, Vlad, Ramanathan, Hishani, Wilkerson, Grace K., Hood, Sean D., Stampfer, Hans, Hulse, Gary K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687673/ https://www.ncbi.nlm.nih.gov/pubmed/36354407 http://dx.doi.org/10.3390/bs12110430 |
Ejemplares similares
-
The role of flumazenil in generalised anxiety disorder: a pilot
naturalistic open-label study with a focus on treatment
resistance
por: Gallo, Alexander T, et al.
Publicado: (2023) -
Is the Precipitation of Anxiety Symptoms Associated with Bolus Doses of Flumazenil a Barrier to Its Use at Low Continuous Doses in Benzodiazepine Withdrawal?
por: Gallo, Alexander, et al.
Publicado: (2022) -
Continuous Infusion of Flumazenil in the Management of Benzodiazepines Detoxification
por: Benini, Anna, et al.
Publicado: (2021) -
Continuous intravenous flumazenil infusion in a patient with chlordiazepoxide toxicity and hepatic encephalopathy
por: Al-Halawani, Moh’d, et al.
Publicado: (2015) -
Continuous Intravenous Flumazenil Infusion Used in Iatrogenic Chlordiazepoxide Overdose in the Setting of Alcoholic Withdrawal Syndrome Management
por: Volney, Giselle S, et al.
Publicado: (2020)